Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA.
Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Transplantation. 2019 Jan;103(1):182-190. doi: 10.1097/TP.0000000000002442.
Regulatory T (Treg) cell-based immunotherapies have been studied as potential cell-based modalities for promoting transplant survival. However, the efficacy of local delivery of Treg cells in corneal transplantation has not been fully elucidated. Herein, we investigated the kinetics of migration of subconjunctivally injected Treg cells and their role in promoting corneal allograft survival.
GFPCD4CD25Foxp3 Treg cells were isolated from draining lymph nodes (DLNs) of GFP transgenic mice and were subconjunctivally injected to corneal allograft recipients. Next, Treg cells, conventional T cells (Tconv) or a combination of both was locally injected to graft recipients, and graft survival was determined by evaluating opacity scores for 10 weeks. Transplanted mice without treatment served as controls. The frequencies of major histocompatibility complex-IICD11b antigen-presenting cells, IFNγCD4 Th1 cells, and CD45 cells in the DLNs and cornea were evaluated at week 2 posttransplantation using flow cytometry. Expressions of IFNγ, IL-10 and TGF-β in the grafts were assessed using reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assay.
GFP Treg cells were detected in the ipsilateral cornea and DLNs of recipients 6 hours after injection. Subconjunctival injection of Treg cells significantly decreased the frequencies of mature antigen-presenting cells in the graft and DLNs, suppressed Th1 frequencies in DLNs, and inhibited CD45 cell infiltration to the graft. Finally, locally delivered Treg cells significantly reduced the expression of IFN-γ, enhanced the levels of IL-10 and TGF-β in the graft, and promoted long-term allograft survival.
Our study elucidates the kinetics of migration of locally delivered Treg cells and shows their role in suppressing host immune response against the allograft.
调节性 T(Treg)细胞为基础的免疫疗法已被研究作为促进移植存活的潜在细胞治疗方式。然而,局部递呈 Treg 细胞在角膜移植中的效果尚未完全阐明。在此,我们研究了结膜下注射 Treg 细胞的迁移动力学及其在促进角膜同种异体移植物存活中的作用。
从 GFP 转基因小鼠引流淋巴结(DLNs)中分离出 GFPCD4CD25Foxp3 Treg 细胞,并结膜下注射至角膜同种异体移植物受者。然后,将 Treg 细胞、常规 T 细胞(Tconv)或两者的组合局部注射至移植物受者,通过 10 周的混浊评分来确定移植物存活。未治疗的移植小鼠作为对照。在移植后第 2 周,通过流式细胞术评估 DLN 和角膜中主要组织相容性复合体-IICD11b 抗原呈递细胞、IFNγCD4 Th1 细胞和 CD45 细胞的频率。通过逆转录聚合酶链反应和酶联免疫吸附试验评估移植物中 IFNγ、IL-10 和 TGF-β 的表达。
注射后 6 小时,GFP Treg 细胞可在受者同侧角膜和 DLN 中检测到。结膜下注射 Treg 细胞可显著降低移植物和 DLN 中成熟抗原呈递细胞的频率,抑制 DLN 中的 Th1 频率,并抑制 CD45 细胞浸润移植物。最后,局部递呈 Treg 细胞可显著降低 IFN-γ的表达,增加移植物中 IL-10 和 TGF-β 的水平,并促进长期同种异体移植物存活。
本研究阐明了局部递呈 Treg 细胞的迁移动力学,并显示了其在抑制宿主对移植物的免疫反应中的作用。